Emmaus Life Sciences, Inc. (EMMA)
0.01
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Emmaus Life Sciences EPS Diluted (Quarterly) : -0.0475 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.335M |
| Revenue (Quarterly) | 1.982M |
| Total Expenses (Quarterly) | 5.317M |
| Enterprise Value | 31.59M |
| Gross Profit Margin (Quarterly) | 91.52% |
| Profit Margin (Quarterly) | -168.3% |
| Earnings Yield | -1.28K% |
| Operating Earnings Yield | 59.13% |
| Normalized Earnings Yield | -1213.00 |